Brookfield Property Partners LP (BPYPP)vsEUDA Health Holdings Limited (EUDA)
BPYPP
Brookfield Property Partners LP
$15.00
+0.94%
REAL ESTATE · Cap: $9.75B
EUDA
EUDA Health Holdings Limited
$11.47
+25.63%
REAL ESTATE · Cap: $692,070
Smart Verdict
WallStSmart Research — data-driven comparison
Brookfield Property Partners LP generates 138400% more annual revenue ($7.15B vs $5.16M). EUDA leads profitability with a 5.2% profit margin vs -5.1%. EUDA trades at a lower P/E of 0.9x. EUDA earns a higher WallStSmart Score of 36/100 (F).
BPYPP
Avoid33
out of 100
Grade: F
EUDA
Hold36
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+84.3%
Fair Value
$102.77
Current Price
$15.00
$87.77 discount
Margin of Safety
+68.0%
Fair Value
$2.72
Current Price
$11.47
$8.75 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Earnings expanding 65.2% YoY
Attractively priced relative to earnings
Revenue surging 60.2% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
ROE of -0.8% — below average capital efficiency
Revenue declined 30.7%
Negative free cash flow — burning cash
Currently unprofitable
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
5.2% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : BPYPP
The strongest argument for BPYPP centers on P/E Ratio, Price/Book, EPS Growth.
Bull Case : EUDA
The strongest argument for EUDA centers on P/E Ratio, Revenue Growth, Debt/Equity. Revenue growth of 60.2% demonstrates continued momentum.
Bear Case : BPYPP
The primary concerns for BPYPP are Return on Equity, Revenue Growth, Free Cash Flow.
Bear Case : EUDA
The primary concerns for EUDA are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
BPYPP profiles as a turnaround stock while EUDA is a hypergrowth play — different risk/reward profiles.
BPYPP carries more volatility with a beta of 0.15 — expect wider price swings.
EUDA is growing revenue faster at 60.2% — sustainability is the question.
EUDA generates stronger free cash flow (-619,323), providing more financial flexibility.
Bottom Line
EUDA scores higher overall (36/100 vs 33/100) and 60.2% revenue growth. BPYPP offers better value entry with a 84.3% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Brookfield Property Partners LP
REAL ESTATE · REAL ESTATE SERVICES · USA
Brookfield Property Partners, through Brookfield Property Partners LP and its subsidiary Brookfield Property REIT Inc., is one of the world's leading real estate companies, with approximately $ 88 billion in total assets.
EUDA Health Holdings Limited
REAL ESTATE · REAL ESTATE SERVICES · USA
EUDA Health Holdings Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative therapies for rare diseases and unmet medical needs. Utilizing advanced technologies and a dynamic pipeline, the company aims to tackle critical challenges in supportive care and immune modulation. With a strong emphasis on research and development, EUDA is well-positioned to lead healthcare innovation, committed to improving patient outcomes and expanding access to vital medical therapies through its promising clinical programs.
Visit Website →Compare with Other REAL ESTATE SERVICES Stocks
Want to dig deeper into these stocks?